nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—KIT—germ cell cancer	0.387	1	CbGaD
Imatinib—PTGS1—Ifosfamide—germ cell cancer	0.0297	0.0909	CbGbCtD
Imatinib—ABCG2—Dactinomycin—germ cell cancer	0.0273	0.0834	CbGbCtD
Imatinib—CYP3A7—Ifosfamide—germ cell cancer	0.0238	0.0728	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.0238	0.0728	CbGbCtD
Imatinib—SLC22A2—Vinblastine—germ cell cancer	0.0231	0.0708	CbGbCtD
Imatinib—SLC22A2—Cisplatin—germ cell cancer	0.0212	0.0649	CbGbCtD
Imatinib—CYP3A5—Ifosfamide—germ cell cancer	0.0178	0.0546	CbGbCtD
Imatinib—ABCG2—Cisplatin—germ cell cancer	0.0157	0.0479	CbGbCtD
Imatinib—ABCG2—Etoposide—germ cell cancer	0.0154	0.0471	CbGbCtD
Imatinib—CYP2C19—Ifosfamide—germ cell cancer	0.0144	0.044	CbGbCtD
Imatinib—PTGS1—Etoposide—germ cell cancer	0.0142	0.0435	CbGbCtD
Imatinib—CYP2C9—Ifosfamide—germ cell cancer	0.012	0.0366	CbGbCtD
Imatinib—ABCG2—Methotrexate—germ cell cancer	0.0102	0.0311	CbGbCtD
Imatinib—ABCB1—Dactinomycin—germ cell cancer	0.00983	0.0301	CbGbCtD
Imatinib—CYP3A5—Etoposide—germ cell cancer	0.00853	0.0261	CbGbCtD
Imatinib—ALB—Methotrexate—germ cell cancer	0.00701	0.0214	CbGbCtD
Imatinib—CYP3A4—Ifosfamide—germ cell cancer	0.00696	0.0213	CbGbCtD
Imatinib—CYP1A2—Etoposide—germ cell cancer	0.00635	0.0194	CbGbCtD
Imatinib—ABCB1—Vinblastine—germ cell cancer	0.00616	0.0188	CbGbCtD
Imatinib—CYP2C9—Cisplatin—germ cell cancer	0.00582	0.0178	CbGbCtD
Imatinib—CYP2D6—Vinblastine—germ cell cancer	0.0058	0.0178	CbGbCtD
Imatinib—ABCB1—Cisplatin—germ cell cancer	0.00565	0.0173	CbGbCtD
Imatinib—ABCB1—Etoposide—germ cell cancer	0.00555	0.017	CbGbCtD
Imatinib—CYP3A4—Vinblastine—germ cell cancer	0.00369	0.0113	CbGbCtD
Imatinib—ABCB1—Methotrexate—germ cell cancer	0.00367	0.0112	CbGbCtD
Imatinib—CYP3A4—Etoposide—germ cell cancer	0.00332	0.0102	CbGbCtD
Imatinib—Ponatinib—FGFR3—germ cell cancer	0.00273	0.562	CrCbGaD
Imatinib—Ponatinib—KIT—germ cell cancer	0.00123	0.252	CrCbGaD
Imatinib—Nilotinib—KIT—germ cell cancer	0.000905	0.186	CrCbGaD
Imatinib—ABL1—embryo—germ cell cancer	0.000237	0.00276	CbGeAlD
Imatinib—LCK—bone marrow—germ cell cancer	0.000236	0.00275	CbGeAlD
Imatinib—PIP4K2C—head—germ cell cancer	0.000235	0.00274	CbGeAlD
Imatinib—CA14—midbrain—germ cell cancer	0.000235	0.00274	CbGeAlD
Imatinib—CSF1R—skin of body—germ cell cancer	0.000233	0.00271	CbGeAlD
Imatinib—PDGFRA—gonad—germ cell cancer	0.000231	0.00269	CbGeAlD
Imatinib—CSF1R—decidua—germ cell cancer	0.000231	0.00269	CbGeAlD
Imatinib—NQO2—uterus—germ cell cancer	0.00023	0.00268	CbGeAlD
Imatinib—CA14—spinal cord—germ cell cancer	0.000229	0.00268	CbGeAlD
Imatinib—PDGFRA—uterus—germ cell cancer	0.000229	0.00268	CbGeAlD
Imatinib—CA3—endocrine gland—germ cell cancer	0.000228	0.00265	CbGeAlD
Imatinib—LCK—female gonad—germ cell cancer	0.000227	0.00265	CbGeAlD
Imatinib—PIP4K2C—testis—germ cell cancer	0.000227	0.00265	CbGeAlD
Imatinib—PTGS1—endothelium—germ cell cancer	0.000226	0.00264	CbGeAlD
Imatinib—NQO2—pituitary gland—germ cell cancer	0.000226	0.00263	CbGeAlD
Imatinib—CA3—head—germ cell cancer	0.000225	0.00262	CbGeAlD
Imatinib—CA1—eye—germ cell cancer	0.000222	0.00259	CbGeAlD
Imatinib—ABL2—cerebellum—germ cell cancer	0.000222	0.00259	CbGeAlD
Imatinib—KIT—telencephalon—germ cell cancer	0.000221	0.00258	CbGeAlD
Imatinib—CA7—cerebellum—germ cell cancer	0.000218	0.00255	CbGeAlD
Imatinib—NQO2—medulla oblongata—germ cell cancer	0.000218	0.00254	CbGeAlD
Imatinib—CA9—endocrine gland—germ cell cancer	0.000218	0.00254	CbGeAlD
Imatinib—ABL1—brainstem—germ cell cancer	0.000217	0.00253	CbGeAlD
Imatinib—CA3—testis—germ cell cancer	0.000217	0.00253	CbGeAlD
Imatinib—PDGFRB—telencephalon—germ cell cancer	0.000216	0.00252	CbGeAlD
Imatinib—ABL1—eye—germ cell cancer	0.000211	0.00246	CbGeAlD
Imatinib—KIT—skin of body—germ cell cancer	0.000211	0.00246	CbGeAlD
Imatinib—SLC47A1—decidua—germ cell cancer	0.000211	0.00246	CbGeAlD
Imatinib—PIP4K2C—cerebellum—germ cell cancer	0.00021	0.00245	CbGeAlD
Imatinib—KIT—decidua—germ cell cancer	0.00021	0.00245	CbGeAlD
Imatinib—ABL1—retina—germ cell cancer	0.000209	0.00244	CbGeAlD
Imatinib—PTGS1—blood vessel—germ cell cancer	0.000209	0.00244	CbGeAlD
Imatinib—CA9—testis—germ cell cancer	0.000208	0.00242	CbGeAlD
Imatinib—PDGFRB—skin of body—germ cell cancer	0.000206	0.00241	CbGeAlD
Imatinib—PDGFRB—decidua—germ cell cancer	0.000205	0.00239	CbGeAlD
Imatinib—CSF1R—gonad—germ cell cancer	0.000203	0.00237	CbGeAlD
Imatinib—CA1—telencephalon—germ cell cancer	0.000202	0.00236	CbGeAlD
Imatinib—CYP3A7—endocrine gland—germ cell cancer	0.000202	0.00236	CbGeAlD
Imatinib—CSF1R—uterus—germ cell cancer	0.000202	0.00236	CbGeAlD
Imatinib—NQO2—adrenal gland—germ cell cancer	0.000202	0.00235	CbGeAlD
Imatinib—LCK—testis—germ cell cancer	0.000202	0.00235	CbGeAlD
Imatinib—PDGFRA—adrenal gland—germ cell cancer	0.000201	0.00235	CbGeAlD
Imatinib—NQO2—midbrain—germ cell cancer	0.000199	0.00232	CbGeAlD
Imatinib—CSF1R—pituitary gland—germ cell cancer	0.000198	0.00231	CbGeAlD
Imatinib—NQO2—bone marrow—germ cell cancer	0.000195	0.00228	CbGeAlD
Imatinib—NQO2—spinal cord—germ cell cancer	0.000194	0.00227	CbGeAlD
Imatinib—PDGFRA—spinal cord—germ cell cancer	0.000194	0.00226	CbGeAlD
Imatinib—CA2—neck—germ cell cancer	0.000193	0.00226	CbGeAlD
Imatinib—ABL1—telencephalon—germ cell cancer	0.000193	0.00225	CbGeAlD
Imatinib—CA9—cerebellum—germ cell cancer	0.000192	0.00224	CbGeAlD
Imatinib—CSF1R—medulla oblongata—germ cell cancer	0.000191	0.00223	CbGeAlD
Imatinib—NQO2—female gonad—germ cell cancer	0.000188	0.00219	CbGeAlD
Imatinib—PDGFRA—female gonad—germ cell cancer	0.000188	0.00219	CbGeAlD
Imatinib—SLC47A1—gonad—germ cell cancer	0.000186	0.00217	CbGeAlD
Imatinib—SLC22A1—telencephalon—germ cell cancer	0.000186	0.00217	CbGeAlD
Imatinib—KIT—gonad—germ cell cancer	0.000185	0.00215	CbGeAlD
Imatinib—SLC47A1—uterus—germ cell cancer	0.000185	0.00215	CbGeAlD
Imatinib—ABL1—skin of body—germ cell cancer	0.000184	0.00214	CbGeAlD
Imatinib—KIT—uterus—germ cell cancer	0.000183	0.00214	CbGeAlD
Imatinib—ABL1—decidua—germ cell cancer	0.000183	0.00213	CbGeAlD
Imatinib—CA14—cerebellum—germ cell cancer	0.000182	0.00212	CbGeAlD
Imatinib—SLC47A1—pituitary gland—germ cell cancer	0.000181	0.00211	CbGeAlD
Imatinib—PDGFRB—gonad—germ cell cancer	0.00018	0.0021	CbGeAlD
Imatinib—ABL2—brain—germ cell cancer	0.00018	0.0021	CbGeAlD
Imatinib—KIT—pituitary gland—germ cell cancer	0.00018	0.0021	CbGeAlD
Imatinib—PDGFRB—uterus—germ cell cancer	0.000179	0.00209	CbGeAlD
Imatinib—CA7—brain—germ cell cancer	0.000177	0.00207	CbGeAlD
Imatinib—CSF1R—adrenal gland—germ cell cancer	0.000177	0.00207	CbGeAlD
Imatinib—PDGFRB—pituitary gland—germ cell cancer	0.000176	0.00205	CbGeAlD
Imatinib—NQO2—endocrine gland—germ cell cancer	0.000175	0.00204	CbGeAlD
Imatinib—CSF1R—midbrain—germ cell cancer	0.000175	0.00204	CbGeAlD
Imatinib—SLC47A1—medulla oblongata—germ cell cancer	0.000175	0.00204	CbGeAlD
Imatinib—PDGFRA—endocrine gland—germ cell cancer	0.000175	0.00204	CbGeAlD
Imatinib—ABL2—lymph node—germ cell cancer	0.000174	0.00203	CbGeAlD
Imatinib—KIT—medulla oblongata—germ cell cancer	0.000174	0.00203	CbGeAlD
Imatinib—NQO2—head—germ cell cancer	0.000173	0.00201	CbGeAlD
Imatinib—PDGFRA—head—germ cell cancer	0.000172	0.00201	CbGeAlD
Imatinib—CSF1R—bone marrow—germ cell cancer	0.000171	0.002	CbGeAlD
Imatinib—CSF1R—spinal cord—germ cell cancer	0.000171	0.00199	CbGeAlD
Imatinib—PIP4K2C—brain—germ cell cancer	0.00017	0.00199	CbGeAlD
Imatinib—PDGFRB—medulla oblongata—germ cell cancer	0.00017	0.00198	CbGeAlD
Imatinib—CA2—trigeminal ganglion—germ cell cancer	0.000167	0.00195	CbGeAlD
Imatinib—NQO2—testis—germ cell cancer	0.000167	0.00195	CbGeAlD
Imatinib—PDGFRA—testis—germ cell cancer	0.000166	0.00194	CbGeAlD
Imatinib—CSF1R—female gonad—germ cell cancer	0.000165	0.00193	CbGeAlD
Imatinib—PIP4K2C—lymph node—germ cell cancer	0.000165	0.00192	CbGeAlD
Imatinib—CA3—brain—germ cell cancer	0.000163	0.0019	CbGeAlD
Imatinib—SLC47A1—adrenal gland—germ cell cancer	0.000162	0.00189	CbGeAlD
Imatinib—CA2—embryo—germ cell cancer	0.000161	0.00188	CbGeAlD
Imatinib—CA12—endocrine gland—germ cell cancer	0.000161	0.00188	CbGeAlD
Imatinib—KIT—adrenal gland—germ cell cancer	0.000161	0.00188	CbGeAlD
Imatinib—ABL1—gonad—germ cell cancer	0.000161	0.00187	CbGeAlD
Imatinib—ABL1—uterus—germ cell cancer	0.00016	0.00186	CbGeAlD
Imatinib—CA12—head—germ cell cancer	0.000159	0.00186	CbGeAlD
Imatinib—KIT—midbrain—germ cell cancer	0.000159	0.00185	CbGeAlD
Imatinib—CA3—lymph node—germ cell cancer	0.000157	0.00183	CbGeAlD
Imatinib—PDGFRB—adrenal gland—germ cell cancer	0.000157	0.00183	CbGeAlD
Imatinib—ABL1—pituitary gland—germ cell cancer	0.000157	0.00183	CbGeAlD
Imatinib—SLC47A1—spinal cord—germ cell cancer	0.000156	0.00182	CbGeAlD
Imatinib—KIT—bone marrow—germ cell cancer	0.000156	0.00182	CbGeAlD
Imatinib—PDGFRB—midbrain—germ cell cancer	0.000155	0.00181	CbGeAlD
Imatinib—KIT—spinal cord—germ cell cancer	0.000155	0.00181	CbGeAlD
Imatinib—ABCG2—trigeminal ganglion—germ cell cancer	0.000155	0.0018	CbGeAlD
Imatinib—NQO2—cerebellum—germ cell cancer	0.000154	0.0018	CbGeAlD
Imatinib—PDGFRA—cerebellum—germ cell cancer	0.000154	0.00179	CbGeAlD
Imatinib—CSF1R—endocrine gland—germ cell cancer	0.000154	0.00179	CbGeAlD
Imatinib—PDGFRB—bone marrow—germ cell cancer	0.000152	0.00177	CbGeAlD
Imatinib—CSF1R—head—germ cell cancer	0.000152	0.00177	CbGeAlD
Imatinib—PDGFRB—spinal cord—germ cell cancer	0.000151	0.00177	CbGeAlD
Imatinib—ABL1—medulla oblongata—germ cell cancer	0.000151	0.00176	CbGeAlD
Imatinib—SLC47A1—female gonad—germ cell cancer	0.000151	0.00176	CbGeAlD
Imatinib—KIT—female gonad—germ cell cancer	0.00015	0.00175	CbGeAlD
Imatinib—CA14—brain—germ cell cancer	0.000148	0.00172	CbGeAlD
Imatinib—CA2—brainstem—germ cell cancer	0.000148	0.00172	CbGeAlD
Imatinib—CSF1R—testis—germ cell cancer	0.000147	0.00171	CbGeAlD
Imatinib—PDGFRB—female gonad—germ cell cancer	0.000147	0.00171	CbGeAlD
Imatinib—LCK—lymph node—germ cell cancer	0.000146	0.00171	CbGeAlD
Imatinib—CA2—eye—germ cell cancer	0.000144	0.00168	CbGeAlD
Imatinib—ORM1—bone marrow—germ cell cancer	0.000143	0.00166	CbGeAlD
Imatinib—CA2—retina—germ cell cancer	0.000143	0.00166	CbGeAlD
Imatinib—CA1—bone marrow—germ cell cancer	0.000142	0.00166	CbGeAlD
Imatinib—ORM1—spinal cord—germ cell cancer	0.000142	0.00166	CbGeAlD
Imatinib—CA1—spinal cord—germ cell cancer	0.000142	0.00165	CbGeAlD
Imatinib—SLC47A1—endocrine gland—germ cell cancer	0.00014	0.00164	CbGeAlD
Imatinib—ABL1—adrenal gland—germ cell cancer	0.00014	0.00163	CbGeAlD
Imatinib—KIT—endocrine gland—germ cell cancer	0.00014	0.00163	CbGeAlD
Imatinib—SLC47A1—head—germ cell cancer	0.000139	0.00162	CbGeAlD
Imatinib—ABL1—midbrain—germ cell cancer	0.000138	0.00161	CbGeAlD
Imatinib—KIT—head—germ cell cancer	0.000138	0.00161	CbGeAlD
Imatinib—PDGFRB—endocrine gland—germ cell cancer	0.000136	0.00159	CbGeAlD
Imatinib—ABL1—bone marrow—germ cell cancer	0.000136	0.00158	CbGeAlD
Imatinib—CSF1R—cerebellum—germ cell cancer	0.000135	0.00158	CbGeAlD
Imatinib—ABL1—spinal cord—germ cell cancer	0.000135	0.00157	CbGeAlD
Imatinib—PDGFRB—head—germ cell cancer	0.000135	0.00157	CbGeAlD
Imatinib—SLC47A1—testis—germ cell cancer	0.000134	0.00156	CbGeAlD
Imatinib—KIT—testis—germ cell cancer	0.000133	0.00155	CbGeAlD
Imatinib—CA2—telencephalon—germ cell cancer	0.000131	0.00153	CbGeAlD
Imatinib—ABL1—female gonad—germ cell cancer	0.000131	0.00152	CbGeAlD
Imatinib—PDGFRB—testis—germ cell cancer	0.00013	0.00152	CbGeAlD
Imatinib—ALB—adrenal gland—germ cell cancer	0.000129	0.00151	CbGeAlD
Imatinib—ORM1—endocrine gland—germ cell cancer	0.000128	0.00149	CbGeAlD
Imatinib—CA1—endocrine gland—germ cell cancer	0.000128	0.00149	CbGeAlD
Imatinib—CA1—head—germ cell cancer	0.000126	0.00147	CbGeAlD
Imatinib—NQO2—brain—germ cell cancer	0.000125	0.00146	CbGeAlD
Imatinib—CA2—skin of body—germ cell cancer	0.000125	0.00146	CbGeAlD
Imatinib—PDGFRA—brain—germ cell cancer	0.000125	0.00146	CbGeAlD
Imatinib—CA2—decidua—germ cell cancer	0.000124	0.00145	CbGeAlD
Imatinib—SLC47A1—cerebellum—germ cell cancer	0.000124	0.00144	CbGeAlD
Imatinib—ABCB1—blood vessel—germ cell cancer	0.000123	0.00144	CbGeAlD
Imatinib—KIT—cerebellum—germ cell cancer	0.000123	0.00143	CbGeAlD
Imatinib—ABL1—endocrine gland—germ cell cancer	0.000121	0.00142	CbGeAlD
Imatinib—ABCG2—telencephalon—germ cell cancer	0.000121	0.00142	CbGeAlD
Imatinib—NQO2—lymph node—germ cell cancer	0.000121	0.00141	CbGeAlD
Imatinib—PDGFRA—lymph node—germ cell cancer	0.000121	0.00141	CbGeAlD
Imatinib—PDGFRB—cerebellum—germ cell cancer	0.00012	0.0014	CbGeAlD
Imatinib—ABL1—head—germ cell cancer	0.00012	0.0014	CbGeAlD
Imatinib—SLC22A1—endocrine gland—germ cell cancer	0.000117	0.00137	CbGeAlD
Imatinib—ABL1—testis—germ cell cancer	0.000116	0.00135	CbGeAlD
Imatinib—SLC22A1—head—germ cell cancer	0.000116	0.00135	CbGeAlD
Imatinib—CA12—brain—germ cell cancer	0.000115	0.00134	CbGeAlD
Imatinib—ABCG2—decidua—germ cell cancer	0.000115	0.00134	CbGeAlD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000111	0.000931	CcSEcCtD
Imatinib—Cardiac disorder—Etoposide—germ cell cancer	0.000111	0.000927	CcSEcCtD
Imatinib—Flushing—Etoposide—germ cell cancer	0.000111	0.000927	CcSEcCtD
Imatinib—Discomfort—Ifosfamide—germ cell cancer	0.00011	0.000926	CcSEcCtD
Imatinib—CSF1R—brain—germ cell cancer	0.00011	0.00128	CbGeAlD
Imatinib—Hypersensitivity—Vinblastine—germ cell cancer	0.000109	0.000917	CcSEcCtD
Imatinib—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000109	0.000917	CcSEcCtD
Imatinib—Decreased appetite—Bleomycin—germ cell cancer	0.000109	0.000914	CcSEcCtD
Imatinib—Muscle spasms—Cisplatin—germ cell cancer	0.000109	0.000913	CcSEcCtD
Imatinib—Angiopathy—Etoposide—germ cell cancer	0.000108	0.000907	CcSEcCtD
Imatinib—Confusional state—Ifosfamide—germ cell cancer	0.000108	0.000906	CcSEcCtD
Imatinib—Immune system disorder—Etoposide—germ cell cancer	0.000108	0.000903	CcSEcCtD
Imatinib—Mediastinal disorder—Etoposide—germ cell cancer	0.000107	0.000901	CcSEcCtD
Imatinib—Pain—Bleomycin—germ cell cancer	0.000107	0.000899	CcSEcCtD
Imatinib—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000107	0.000899	CcSEcCtD
Imatinib—Oedema—Ifosfamide—germ cell cancer	0.000107	0.000899	CcSEcCtD
Imatinib—ABL1—cerebellum—germ cell cancer	0.000107	0.00125	CbGeAlD
Imatinib—ALB—testis—germ cell cancer	0.000107	0.00125	CbGeAlD
Imatinib—Chills—Etoposide—germ cell cancer	0.000107	0.000897	CcSEcCtD
Imatinib—CA2—pituitary gland—germ cell cancer	0.000107	0.00125	CbGeAlD
Imatinib—Vision blurred—Cisplatin—germ cell cancer	0.000107	0.000895	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000107	0.000894	CcSEcCtD
Imatinib—Asthenia—Vinblastine—germ cell cancer	0.000107	0.000893	CcSEcCtD
Imatinib—Infection—Ifosfamide—germ cell cancer	0.000106	0.000893	CcSEcCtD
Imatinib—CSF1R—lymph node—germ cell cancer	0.000106	0.00124	CbGeAlD
Imatinib—Tremor—Cisplatin—germ cell cancer	0.000106	0.00089	CcSEcCtD
Imatinib—Alopecia—Etoposide—germ cell cancer	0.000105	0.000883	CcSEcCtD
Imatinib—Lethargy—Methotrexate—germ cell cancer	0.000105	0.000883	CcSEcCtD
Imatinib—Nervous system disorder—Ifosfamide—germ cell cancer	0.000105	0.000881	CcSEcCtD
Imatinib—Ill-defined disorder—Cisplatin—germ cell cancer	0.000105	0.000881	CcSEcCtD
Imatinib—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000105	0.00088	CcSEcCtD
Imatinib—Anaemia—Cisplatin—germ cell cancer	0.000105	0.000878	CcSEcCtD
Imatinib—Skin disorder—Ifosfamide—germ cell cancer	0.000104	0.000873	CcSEcCtD
Imatinib—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000104	0.000869	CcSEcCtD
Imatinib—Feeling abnormal—Bleomycin—germ cell cancer	0.000103	0.000867	CcSEcCtD
Imatinib—CA2—medulla oblongata—germ cell cancer	0.000103	0.0012	CbGeAlD
Imatinib—Anorexia—Ifosfamide—germ cell cancer	0.000102	0.000857	CcSEcCtD
Imatinib—Malaise—Cisplatin—germ cell cancer	0.000102	0.000856	CcSEcCtD
Imatinib—Decreased appetite—Dactinomycin—germ cell cancer	0.000102	0.000853	CcSEcCtD
Imatinib—Diarrhoea—Vinblastine—germ cell cancer	0.000102	0.000852	CcSEcCtD
Imatinib—Dysgeusia—Etoposide—germ cell cancer	0.000102	0.000852	CcSEcCtD
Imatinib—Leukopenia—Cisplatin—germ cell cancer	0.000101	0.00085	CcSEcCtD
Imatinib—PTGS1—telencephalon—germ cell cancer	0.000101	0.00118	CbGeAlD
Imatinib—Fatigue—Dactinomycin—germ cell cancer	0.000101	0.000846	CcSEcCtD
Imatinib—ABCG2—uterus—germ cell cancer	0.000101	0.00117	CbGeAlD
Imatinib—SLC47A1—brain—germ cell cancer	0.0001	0.00117	CbGeAlD
Imatinib—Back pain—Etoposide—germ cell cancer	0.0001	0.000841	CcSEcCtD
Imatinib—Hypotension—Ifosfamide—germ cell cancer	0.0001	0.00084	CcSEcCtD
Imatinib—Pain—Dactinomycin—germ cell cancer	0.0001	0.000839	CcSEcCtD
Imatinib—KIT—brain—germ cell cancer	9.98e-05	0.00116	CbGeAlD
Imatinib—Muscle spasms—Etoposide—germ cell cancer	9.97e-05	0.000836	CcSEcCtD
Imatinib—Urticaria—Bleomycin—germ cell cancer	9.96e-05	0.000835	CcSEcCtD
Imatinib—Body temperature increased—Bleomycin—germ cell cancer	9.91e-05	0.000831	CcSEcCtD
Imatinib—ABCG2—pituitary gland—germ cell cancer	9.89e-05	0.00115	CbGeAlD
Imatinib—Dizziness—Vinblastine—germ cell cancer	9.82e-05	0.000823	CcSEcCtD
Imatinib—Convulsion—Cisplatin—germ cell cancer	9.81e-05	0.000823	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	9.77e-05	0.000819	CcSEcCtD
Imatinib—PDGFRB—brain—germ cell cancer	9.75e-05	0.00114	CbGeAlD
Imatinib—SLC47A1—lymph node—germ cell cancer	9.7e-05	0.00113	CbGeAlD
Imatinib—PTGS1—skin of body—germ cell cancer	9.67e-05	0.00113	CbGeAlD
Imatinib—KIT—lymph node—germ cell cancer	9.65e-05	0.00113	CbGeAlD
Imatinib—Myalgia—Cisplatin—germ cell cancer	9.64e-05	0.000808	CcSEcCtD
Imatinib—Feeling abnormal—Dactinomycin—germ cell cancer	9.64e-05	0.000808	CcSEcCtD
Imatinib—Paraesthesia—Ifosfamide—germ cell cancer	9.62e-05	0.000807	CcSEcCtD
Imatinib—Ill-defined disorder—Etoposide—germ cell cancer	9.62e-05	0.000807	CcSEcCtD
Imatinib—Anxiety—Cisplatin—germ cell cancer	9.61e-05	0.000806	CcSEcCtD
Imatinib—Anaemia—Etoposide—germ cell cancer	9.59e-05	0.000804	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	9.57e-05	0.000803	CcSEcCtD
Imatinib—Gastrointestinal pain—Dactinomycin—germ cell cancer	9.56e-05	0.000802	CcSEcCtD
Imatinib—Dyspnoea—Ifosfamide—germ cell cancer	9.56e-05	0.000801	CcSEcCtD
Imatinib—ABCG2—medulla oblongata—germ cell cancer	9.54e-05	0.00111	CbGeAlD
Imatinib—CA2—adrenal gland—germ cell cancer	9.54e-05	0.00111	CbGeAlD
Imatinib—Somnolence—Ifosfamide—germ cell cancer	9.53e-05	0.000799	CcSEcCtD
Imatinib—Discomfort—Cisplatin—germ cell cancer	9.52e-05	0.000799	CcSEcCtD
Imatinib—Vomiting—Vinblastine—germ cell cancer	9.44e-05	0.000792	CcSEcCtD
Imatinib—PDGFRB—lymph node—germ cell cancer	9.42e-05	0.0011	CbGeAlD
Imatinib—CA2—midbrain—germ cell cancer	9.42e-05	0.0011	CbGeAlD
Imatinib—CYP2D6—brainstem—germ cell cancer	9.38e-05	0.00109	CbGeAlD
Imatinib—Malaise—Etoposide—germ cell cancer	9.35e-05	0.000784	CcSEcCtD
Imatinib—Breast disorder—Methotrexate—germ cell cancer	9.32e-05	0.000782	CcSEcCtD
Imatinib—Vertigo—Etoposide—germ cell cancer	9.32e-05	0.000781	CcSEcCtD
Imatinib—Decreased appetite—Ifosfamide—germ cell cancer	9.32e-05	0.000781	CcSEcCtD
Imatinib—Headache—Vinblastine—germ cell cancer	9.3e-05	0.00078	CcSEcCtD
Imatinib—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	9.29e-05	0.000779	CcSEcCtD
Imatinib—Leukopenia—Etoposide—germ cell cancer	9.28e-05	0.000779	CcSEcCtD
Imatinib—Gastrointestinal disorder—Ifosfamide—germ cell cancer	9.25e-05	0.000776	CcSEcCtD
Imatinib—Body temperature increased—Dactinomycin—germ cell cancer	9.25e-05	0.000775	CcSEcCtD
Imatinib—Abdominal pain—Dactinomycin—germ cell cancer	9.25e-05	0.000775	CcSEcCtD
Imatinib—Fatigue—Ifosfamide—germ cell cancer	9.24e-05	0.000775	CcSEcCtD
Imatinib—Oedema—Cisplatin—germ cell cancer	9.24e-05	0.000775	CcSEcCtD
Imatinib—Anaphylactic shock—Cisplatin—germ cell cancer	9.24e-05	0.000775	CcSEcCtD
Imatinib—Hypersensitivity—Bleomycin—germ cell cancer	9.24e-05	0.000775	CcSEcCtD
Imatinib—CA2—bone marrow—germ cell cancer	9.23e-05	0.00108	CbGeAlD
Imatinib—CA2—spinal cord—germ cell cancer	9.19e-05	0.00107	CbGeAlD
Imatinib—Infection—Cisplatin—germ cell cancer	9.18e-05	0.00077	CcSEcCtD
Imatinib—Constipation—Ifosfamide—germ cell cancer	9.17e-05	0.000769	CcSEcCtD
Imatinib—Pain—Ifosfamide—germ cell cancer	9.17e-05	0.000769	CcSEcCtD
Imatinib—CA1—brain—germ cell cancer	9.13e-05	0.00106	CbGeAlD
Imatinib—Loss of consciousness—Etoposide—germ cell cancer	9.12e-05	0.000765	CcSEcCtD
Imatinib—Nervous system disorder—Cisplatin—germ cell cancer	9.06e-05	0.00076	CcSEcCtD
Imatinib—Cough—Etoposide—germ cell cancer	9.05e-05	0.000759	CcSEcCtD
Imatinib—Thrombocytopenia—Cisplatin—germ cell cancer	9.05e-05	0.000759	CcSEcCtD
Imatinib—CYP2C19—endocrine gland—germ cell cancer	9.03e-05	0.00105	CbGeAlD
Imatinib—Tachycardia—Cisplatin—germ cell cancer	9.02e-05	0.000756	CcSEcCtD
Imatinib—Asthenia—Bleomycin—germ cell cancer	9e-05	0.000755	CcSEcCtD
Imatinib—Convulsion—Etoposide—germ cell cancer	8.99e-05	0.000754	CcSEcCtD
Imatinib—Skin disorder—Cisplatin—germ cell cancer	8.98e-05	0.000753	CcSEcCtD
Imatinib—Hypertension—Etoposide—germ cell cancer	8.96e-05	0.000751	CcSEcCtD
Imatinib—Hyperhidrosis—Cisplatin—germ cell cancer	8.93e-05	0.000749	CcSEcCtD
Imatinib—CA2—female gonad—germ cell cancer	8.9e-05	0.00104	CbGeAlD
Imatinib—Pruritus—Bleomycin—germ cell cancer	8.87e-05	0.000744	CcSEcCtD
Imatinib—ORM1—lymph node—germ cell cancer	8.84e-05	0.00103	CbGeAlD
Imatinib—ABCG2—adrenal gland—germ cell cancer	8.83e-05	0.00103	CbGeAlD
Imatinib—Feeling abnormal—Ifosfamide—germ cell cancer	8.83e-05	0.000741	CcSEcCtD
Imatinib—Chest pain—Etoposide—germ cell cancer	8.83e-05	0.000741	CcSEcCtD
Imatinib—Eosinophilia—Methotrexate—germ cell cancer	8.83e-05	0.00074	CcSEcCtD
Imatinib—CA1—lymph node—germ cell cancer	8.82e-05	0.00103	CbGeAlD
Imatinib—Nausea—Vinblastine—germ cell cancer	8.82e-05	0.00074	CcSEcCtD
Imatinib—Anorexia—Cisplatin—germ cell cancer	8.81e-05	0.000739	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	8.77e-05	0.000735	CcSEcCtD
Imatinib—Gastrointestinal pain—Ifosfamide—germ cell cancer	8.76e-05	0.000735	CcSEcCtD
Imatinib—Pancreatitis—Methotrexate—germ cell cancer	8.74e-05	0.000733	CcSEcCtD
Imatinib—Discomfort—Etoposide—germ cell cancer	8.72e-05	0.000732	CcSEcCtD
Imatinib—ABCG2—midbrain—germ cell cancer	8.72e-05	0.00102	CbGeAlD
Imatinib—ABL1—brain—germ cell cancer	8.69e-05	0.00101	CbGeAlD
Imatinib—Hypotension—Cisplatin—germ cell cancer	8.63e-05	0.000724	CcSEcCtD
Imatinib—Hypersensitivity—Dactinomycin—germ cell cancer	8.62e-05	0.000723	CcSEcCtD
Imatinib—ABCG2—bone marrow—germ cell cancer	8.55e-05	0.000997	CbGeAlD
Imatinib—Confusional state—Etoposide—germ cell cancer	8.54e-05	0.000716	CcSEcCtD
Imatinib—Urticaria—Ifosfamide—germ cell cancer	8.51e-05	0.000714	CcSEcCtD
Imatinib—ABCG2—spinal cord—germ cell cancer	8.51e-05	0.000992	CbGeAlD
Imatinib—Abdominal pain—Ifosfamide—germ cell cancer	8.47e-05	0.000711	CcSEcCtD
Imatinib—Body temperature increased—Ifosfamide—germ cell cancer	8.47e-05	0.000711	CcSEcCtD
Imatinib—Pancytopenia—Methotrexate—germ cell cancer	8.47e-05	0.00071	CcSEcCtD
Imatinib—Anaphylactic shock—Etoposide—germ cell cancer	8.47e-05	0.00071	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Cisplatin—germ cell cancer	8.42e-05	0.000706	CcSEcCtD
Imatinib—Infection—Etoposide—germ cell cancer	8.41e-05	0.000705	CcSEcCtD
Imatinib—PTGS1—uterus—germ cell cancer	8.4e-05	0.00098	CbGeAlD
Imatinib—ABL1—lymph node—germ cell cancer	8.4e-05	0.000979	CbGeAlD
Imatinib—Asthenia—Dactinomycin—germ cell cancer	8.39e-05	0.000704	CcSEcCtD
Imatinib—SLC22A1—brain—germ cell cancer	8.38e-05	0.000977	CbGeAlD
Imatinib—Neutropenia—Methotrexate—germ cell cancer	8.34e-05	0.000699	CcSEcCtD
Imatinib—CYP2D6—telencephalon—germ cell cancer	8.33e-05	0.000971	CbGeAlD
Imatinib—Paraesthesia—Cisplatin—germ cell cancer	8.3e-05	0.000696	CcSEcCtD
Imatinib—Thrombocytopenia—Etoposide—germ cell cancer	8.29e-05	0.000695	CcSEcCtD
Imatinib—Upper respiratory tract infection—Methotrexate—germ cell cancer	8.29e-05	0.000695	CcSEcCtD
Imatinib—CA2—endocrine gland—germ cell cancer	8.27e-05	0.000965	CbGeAlD
Imatinib—Tachycardia—Etoposide—germ cell cancer	8.26e-05	0.000693	CcSEcCtD
Imatinib—PTGS1—pituitary gland—germ cell cancer	8.25e-05	0.000962	CbGeAlD
Imatinib—Dyspnoea—Cisplatin—germ cell cancer	8.24e-05	0.000691	CcSEcCtD
Imatinib—ABCG2—female gonad—germ cell cancer	8.24e-05	0.000961	CbGeAlD
Imatinib—Skin disorder—Etoposide—germ cell cancer	8.22e-05	0.00069	CcSEcCtD
Imatinib—Erectile dysfunction—Methotrexate—germ cell cancer	8.21e-05	0.000689	CcSEcCtD
Imatinib—Hyperhidrosis—Etoposide—germ cell cancer	8.18e-05	0.000686	CcSEcCtD
Imatinib—CA2—head—germ cell cancer	8.17e-05	0.000952	CbGeAlD
Imatinib—Photosensitivity reaction—Methotrexate—germ cell cancer	8.14e-05	0.000683	CcSEcCtD
Imatinib—Anorexia—Etoposide—germ cell cancer	8.07e-05	0.000677	CcSEcCtD
Imatinib—Decreased appetite—Cisplatin—germ cell cancer	8.03e-05	0.000674	CcSEcCtD
Imatinib—ALB—brain—germ cell cancer	8.02e-05	0.000935	CbGeAlD
Imatinib—Diarrhoea—Dactinomycin—germ cell cancer	8e-05	0.000671	CcSEcCtD
Imatinib—Pneumonia—Methotrexate—germ cell cancer	8e-05	0.000671	CcSEcCtD
Imatinib—Gastrointestinal disorder—Cisplatin—germ cell cancer	7.98e-05	0.000669	CcSEcCtD
Imatinib—Vomiting—Bleomycin—germ cell cancer	7.97e-05	0.000669	CcSEcCtD
Imatinib—Infestation NOS—Methotrexate—germ cell cancer	7.95e-05	0.000667	CcSEcCtD
Imatinib—Infestation—Methotrexate—germ cell cancer	7.95e-05	0.000667	CcSEcCtD
Imatinib—Depression—Methotrexate—germ cell cancer	7.93e-05	0.000665	CcSEcCtD
Imatinib—Hypotension—Etoposide—germ cell cancer	7.91e-05	0.000663	CcSEcCtD
Imatinib—Rash—Bleomycin—germ cell cancer	7.91e-05	0.000663	CcSEcCtD
Imatinib—Pain—Cisplatin—germ cell cancer	7.9e-05	0.000663	CcSEcCtD
Imatinib—Dermatitis—Bleomycin—germ cell cancer	7.9e-05	0.000663	CcSEcCtD
Imatinib—Hypersensitivity—Ifosfamide—germ cell cancer	7.9e-05	0.000662	CcSEcCtD
Imatinib—CA2—testis—germ cell cancer	7.89e-05	0.00092	CbGeAlD
Imatinib—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	7.88e-05	0.000661	CcSEcCtD
Imatinib—Renal failure—Methotrexate—germ cell cancer	7.82e-05	0.000655	CcSEcCtD
Imatinib—ALB—lymph node—germ cell cancer	7.75e-05	0.000904	CbGeAlD
Imatinib—Stomatitis—Methotrexate—germ cell cancer	7.75e-05	0.00065	CcSEcCtD
Imatinib—Conjunctivitis—Methotrexate—germ cell cancer	7.73e-05	0.000648	CcSEcCtD
Imatinib—Asthenia—Ifosfamide—germ cell cancer	7.69e-05	0.000645	CcSEcCtD
Imatinib—CYP3A5—female gonad—germ cell cancer	7.65e-05	0.000892	CbGeAlD
Imatinib—ABCB1—trigeminal ganglion—germ cell cancer	7.63e-05	0.000889	CbGeAlD
Imatinib—Sweating—Methotrexate—germ cell cancer	7.62e-05	0.000639	CcSEcCtD
Imatinib—Feeling abnormal—Cisplatin—germ cell cancer	7.61e-05	0.000639	CcSEcCtD
Imatinib—Paraesthesia—Etoposide—germ cell cancer	7.6e-05	0.000637	CcSEcCtD
Imatinib—Pruritus—Ifosfamide—germ cell cancer	7.58e-05	0.000636	CcSEcCtD
Imatinib—Haematuria—Methotrexate—germ cell cancer	7.58e-05	0.000636	CcSEcCtD
Imatinib—Dyspnoea—Etoposide—germ cell cancer	7.55e-05	0.000633	CcSEcCtD
Imatinib—Somnolence—Etoposide—germ cell cancer	7.53e-05	0.000631	CcSEcCtD
Imatinib—Hepatobiliary disease—Methotrexate—germ cell cancer	7.52e-05	0.000631	CcSEcCtD
Imatinib—Epistaxis—Methotrexate—germ cell cancer	7.5e-05	0.000629	CcSEcCtD
Imatinib—Nausea—Bleomycin—germ cell cancer	7.45e-05	0.000625	CcSEcCtD
Imatinib—Vomiting—Dactinomycin—germ cell cancer	7.44e-05	0.000624	CcSEcCtD
Imatinib—Agranulocytosis—Methotrexate—germ cell cancer	7.42e-05	0.000622	CcSEcCtD
Imatinib—Rash—Dactinomycin—germ cell cancer	7.37e-05	0.000618	CcSEcCtD
Imatinib—CYP1A2—endocrine gland—germ cell cancer	7.37e-05	0.00086	CbGeAlD
Imatinib—PTGS1—adrenal gland—germ cell cancer	7.37e-05	0.000859	CbGeAlD
Imatinib—ABCB1—embryo—germ cell cancer	7.36e-05	0.000859	CbGeAlD
Imatinib—Decreased appetite—Etoposide—germ cell cancer	7.36e-05	0.000617	CcSEcCtD
Imatinib—Diarrhoea—Ifosfamide—germ cell cancer	7.33e-05	0.000615	CcSEcCtD
Imatinib—Gastrointestinal disorder—Etoposide—germ cell cancer	7.31e-05	0.000613	CcSEcCtD
Imatinib—ABCG2—testis—germ cell cancer	7.31e-05	0.000852	CbGeAlD
Imatinib—Body temperature increased—Cisplatin—germ cell cancer	7.3e-05	0.000613	CcSEcCtD
Imatinib—Fatigue—Etoposide—germ cell cancer	7.3e-05	0.000612	CcSEcCtD
Imatinib—CA2—cerebellum—germ cell cancer	7.29e-05	0.00085	CbGeAlD
Imatinib—Constipation—Etoposide—germ cell cancer	7.24e-05	0.000607	CcSEcCtD
Imatinib—Pain—Etoposide—germ cell cancer	7.24e-05	0.000607	CcSEcCtD
Imatinib—Haemoglobin—Methotrexate—germ cell cancer	7.17e-05	0.000602	CcSEcCtD
Imatinib—Hepatitis—Methotrexate—germ cell cancer	7.14e-05	0.000599	CcSEcCtD
Imatinib—Haemorrhage—Methotrexate—germ cell cancer	7.14e-05	0.000599	CcSEcCtD
Imatinib—CYP3A5—endocrine gland—germ cell cancer	7.11e-05	0.000829	CbGeAlD
Imatinib—PTGS1—spinal cord—germ cell cancer	7.1e-05	0.000828	CbGeAlD
Imatinib—Dizziness—Ifosfamide—germ cell cancer	7.09e-05	0.000594	CcSEcCtD
Imatinib—Pharyngitis—Methotrexate—germ cell cancer	7.08e-05	0.000594	CcSEcCtD
Imatinib—Urinary tract disorder—Methotrexate—germ cell cancer	7.05e-05	0.000591	CcSEcCtD
Imatinib—CYP2C9—endocrine gland—germ cell cancer	7e-05	0.000816	CbGeAlD
Imatinib—Urethral disorder—Methotrexate—germ cell cancer	7e-05	0.000587	CcSEcCtD
Imatinib—Feeling abnormal—Etoposide—germ cell cancer	6.98e-05	0.000585	CcSEcCtD
Imatinib—Nausea—Dactinomycin—germ cell cancer	6.95e-05	0.000583	CcSEcCtD
Imatinib—Gastrointestinal pain—Etoposide—germ cell cancer	6.92e-05	0.00058	CcSEcCtD
Imatinib—PTGS1—female gonad—germ cell cancer	6.87e-05	0.000801	CbGeAlD
Imatinib—Vomiting—Ifosfamide—germ cell cancer	6.81e-05	0.000571	CcSEcCtD
Imatinib—Hypersensitivity—Cisplatin—germ cell cancer	6.81e-05	0.000571	CcSEcCtD
Imatinib—Rash—Ifosfamide—germ cell cancer	6.76e-05	0.000567	CcSEcCtD
Imatinib—Dermatitis—Ifosfamide—germ cell cancer	6.75e-05	0.000566	CcSEcCtD
Imatinib—Erythema multiforme—Methotrexate—germ cell cancer	6.75e-05	0.000566	CcSEcCtD
Imatinib—ABCG2—cerebellum—germ cell cancer	6.75e-05	0.000787	CbGeAlD
Imatinib—Urticaria—Etoposide—germ cell cancer	6.73e-05	0.000564	CcSEcCtD
Imatinib—Abdominal pain—Etoposide—germ cell cancer	6.69e-05	0.000561	CcSEcCtD
Imatinib—Body temperature increased—Etoposide—germ cell cancer	6.69e-05	0.000561	CcSEcCtD
Imatinib—Eye disorder—Methotrexate—germ cell cancer	6.67e-05	0.000559	CcSEcCtD
Imatinib—Tinnitus—Methotrexate—germ cell cancer	6.65e-05	0.000558	CcSEcCtD
Imatinib—Asthenia—Cisplatin—germ cell cancer	6.63e-05	0.000556	CcSEcCtD
Imatinib—Cardiac disorder—Methotrexate—germ cell cancer	6.62e-05	0.000555	CcSEcCtD
Imatinib—ABCB1—retina—germ cell cancer	6.51e-05	0.000759	CbGeAlD
Imatinib—Angiopathy—Methotrexate—germ cell cancer	6.48e-05	0.000543	CcSEcCtD
Imatinib—Immune system disorder—Methotrexate—germ cell cancer	6.45e-05	0.000541	CcSEcCtD
Imatinib—Mediastinal disorder—Methotrexate—germ cell cancer	6.43e-05	0.000539	CcSEcCtD
Imatinib—Chills—Methotrexate—germ cell cancer	6.4e-05	0.000537	CcSEcCtD
Imatinib—PTGS1—endocrine gland—germ cell cancer	6.39e-05	0.000745	CbGeAlD
Imatinib—Nausea—Ifosfamide—germ cell cancer	6.37e-05	0.000534	CcSEcCtD
Imatinib—Diarrhoea—Cisplatin—germ cell cancer	6.32e-05	0.00053	CcSEcCtD
Imatinib—PTGS1—head—germ cell cancer	6.31e-05	0.000736	CbGeAlD
Imatinib—Alopecia—Methotrexate—germ cell cancer	6.31e-05	0.000529	CcSEcCtD
Imatinib—Mental disorder—Methotrexate—germ cell cancer	6.25e-05	0.000524	CcSEcCtD
Imatinib—Hypersensitivity—Etoposide—germ cell cancer	6.24e-05	0.000523	CcSEcCtD
Imatinib—Erythema—Methotrexate—germ cell cancer	6.21e-05	0.000521	CcSEcCtD
Imatinib—Malnutrition—Methotrexate—germ cell cancer	6.21e-05	0.000521	CcSEcCtD
Imatinib—PTGS1—testis—germ cell cancer	6.09e-05	0.000711	CbGeAlD
Imatinib—Dysgeusia—Methotrexate—germ cell cancer	6.08e-05	0.00051	CcSEcCtD
Imatinib—Asthenia—Etoposide—germ cell cancer	6.07e-05	0.000509	CcSEcCtD
Imatinib—Back pain—Methotrexate—germ cell cancer	6.01e-05	0.000504	CcSEcCtD
Imatinib—ABCB1—telencephalon—germ cell cancer	5.99e-05	0.000698	CbGeAlD
Imatinib—Pruritus—Etoposide—germ cell cancer	5.99e-05	0.000502	CcSEcCtD
Imatinib—CA2—brain—germ cell cancer	5.92e-05	0.00069	CbGeAlD
Imatinib—Vomiting—Cisplatin—germ cell cancer	5.88e-05	0.000493	CcSEcCtD
Imatinib—Vision blurred—Methotrexate—germ cell cancer	5.86e-05	0.000491	CcSEcCtD
Imatinib—Rash—Cisplatin—germ cell cancer	5.83e-05	0.000489	CcSEcCtD
Imatinib—Dermatitis—Cisplatin—germ cell cancer	5.82e-05	0.000488	CcSEcCtD
Imatinib—Diarrhoea—Etoposide—germ cell cancer	5.79e-05	0.000486	CcSEcCtD
Imatinib—Ill-defined disorder—Methotrexate—germ cell cancer	5.76e-05	0.000483	CcSEcCtD
Imatinib—Anaemia—Methotrexate—germ cell cancer	5.74e-05	0.000482	CcSEcCtD
Imatinib—CA2—lymph node—germ cell cancer	5.72e-05	0.000667	CbGeAlD
Imatinib—ABCB1—decidua—germ cell cancer	5.68e-05	0.000662	CbGeAlD
Imatinib—CYP2D6—female gonad—germ cell cancer	5.65e-05	0.000659	CbGeAlD
Imatinib—Malaise—Methotrexate—germ cell cancer	5.6e-05	0.00047	CcSEcCtD
Imatinib—Dizziness—Etoposide—germ cell cancer	5.6e-05	0.000469	CcSEcCtD
Imatinib—Vertigo—Methotrexate—germ cell cancer	5.58e-05	0.000468	CcSEcCtD
Imatinib—Leukopenia—Methotrexate—germ cell cancer	5.56e-05	0.000466	CcSEcCtD
Imatinib—Nausea—Cisplatin—germ cell cancer	5.49e-05	0.00046	CcSEcCtD
Imatinib—ABCG2—brain—germ cell cancer	5.48e-05	0.000639	CbGeAlD
Imatinib—Cough—Methotrexate—germ cell cancer	5.42e-05	0.000455	CcSEcCtD
Imatinib—Convulsion—Methotrexate—germ cell cancer	5.38e-05	0.000451	CcSEcCtD
Imatinib—Vomiting—Etoposide—germ cell cancer	5.38e-05	0.000451	CcSEcCtD
Imatinib—Rash—Etoposide—germ cell cancer	5.34e-05	0.000448	CcSEcCtD
Imatinib—CYP3A4—endocrine gland—germ cell cancer	5.34e-05	0.000622	CbGeAlD
Imatinib—Dermatitis—Etoposide—germ cell cancer	5.33e-05	0.000447	CcSEcCtD
Imatinib—Headache—Etoposide—germ cell cancer	5.3e-05	0.000445	CcSEcCtD
Imatinib—ABCG2—lymph node—germ cell cancer	5.3e-05	0.000618	CbGeAlD
Imatinib—Chest pain—Methotrexate—germ cell cancer	5.29e-05	0.000444	CcSEcCtD
Imatinib—Myalgia—Methotrexate—germ cell cancer	5.29e-05	0.000444	CcSEcCtD
Imatinib—Arthralgia—Methotrexate—germ cell cancer	5.29e-05	0.000444	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	5.25e-05	0.000441	CcSEcCtD
Imatinib—CYP2D6—endocrine gland—germ cell cancer	5.25e-05	0.000612	CbGeAlD
Imatinib—Discomfort—Methotrexate—germ cell cancer	5.23e-05	0.000438	CcSEcCtD
Imatinib—CYP2D6—head—germ cell cancer	5.18e-05	0.000605	CbGeAlD
Imatinib—Confusional state—Methotrexate—germ cell cancer	5.11e-05	0.000429	CcSEcCtD
Imatinib—Anaphylactic shock—Methotrexate—germ cell cancer	5.07e-05	0.000425	CcSEcCtD
Imatinib—Infection—Methotrexate—germ cell cancer	5.04e-05	0.000422	CcSEcCtD
Imatinib—Nausea—Etoposide—germ cell cancer	5.03e-05	0.000422	CcSEcCtD
Imatinib—CYP2D6—testis—germ cell cancer	5.01e-05	0.000584	CbGeAlD
Imatinib—ABCB1—gonad—germ cell cancer	5e-05	0.000583	CbGeAlD
Imatinib—Nervous system disorder—Methotrexate—germ cell cancer	4.97e-05	0.000417	CcSEcCtD
Imatinib—ABCB1—uterus—germ cell cancer	4.97e-05	0.000579	CbGeAlD
Imatinib—Thrombocytopenia—Methotrexate—germ cell cancer	4.96e-05	0.000416	CcSEcCtD
Imatinib—Skin disorder—Methotrexate—germ cell cancer	4.93e-05	0.000413	CcSEcCtD
Imatinib—Hyperhidrosis—Methotrexate—germ cell cancer	4.9e-05	0.000411	CcSEcCtD
Imatinib—ABCB1—pituitary gland—germ cell cancer	4.88e-05	0.000569	CbGeAlD
Imatinib—Anorexia—Methotrexate—germ cell cancer	4.83e-05	0.000405	CcSEcCtD
Imatinib—Hypotension—Methotrexate—germ cell cancer	4.74e-05	0.000397	CcSEcCtD
Imatinib—ABCB1—medulla oblongata—germ cell cancer	4.71e-05	0.000549	CbGeAlD
Imatinib—CYP2D6—cerebellum—germ cell cancer	4.63e-05	0.000539	CbGeAlD
Imatinib—Musculoskeletal discomfort—Methotrexate—germ cell cancer	4.62e-05	0.000387	CcSEcCtD
Imatinib—Insomnia—Methotrexate—germ cell cancer	4.59e-05	0.000385	CcSEcCtD
Imatinib—PTGS1—brain—germ cell cancer	4.57e-05	0.000533	CbGeAlD
Imatinib—Paraesthesia—Methotrexate—germ cell cancer	4.55e-05	0.000382	CcSEcCtD
Imatinib—Dyspnoea—Methotrexate—germ cell cancer	4.52e-05	0.000379	CcSEcCtD
Imatinib—Somnolence—Methotrexate—germ cell cancer	4.51e-05	0.000378	CcSEcCtD
Imatinib—Dyspepsia—Methotrexate—germ cell cancer	4.46e-05	0.000374	CcSEcCtD
Imatinib—PTGS1—lymph node—germ cell cancer	4.42e-05	0.000515	CbGeAlD
Imatinib—Decreased appetite—Methotrexate—germ cell cancer	4.41e-05	0.00037	CcSEcCtD
Imatinib—Gastrointestinal disorder—Methotrexate—germ cell cancer	4.38e-05	0.000367	CcSEcCtD
Imatinib—Fatigue—Methotrexate—germ cell cancer	4.37e-05	0.000367	CcSEcCtD
Imatinib—ABCB1—adrenal gland—germ cell cancer	4.36e-05	0.000508	CbGeAlD
Imatinib—Pain—Methotrexate—germ cell cancer	4.34e-05	0.000364	CcSEcCtD
Imatinib—ABCB1—midbrain—germ cell cancer	4.3e-05	0.000502	CbGeAlD
Imatinib—ABCB1—bone marrow—germ cell cancer	4.21e-05	0.000492	CbGeAlD
Imatinib—ABCB1—spinal cord—germ cell cancer	4.2e-05	0.000489	CbGeAlD
Imatinib—Feeling abnormal—Methotrexate—germ cell cancer	4.18e-05	0.00035	CcSEcCtD
Imatinib—Gastrointestinal pain—Methotrexate—germ cell cancer	4.15e-05	0.000348	CcSEcCtD
Imatinib—ABCB1—female gonad—germ cell cancer	4.06e-05	0.000474	CbGeAlD
Imatinib—Urticaria—Methotrexate—germ cell cancer	4.03e-05	0.000338	CcSEcCtD
Imatinib—Abdominal pain—Methotrexate—germ cell cancer	4.01e-05	0.000336	CcSEcCtD
Imatinib—Body temperature increased—Methotrexate—germ cell cancer	4.01e-05	0.000336	CcSEcCtD
Imatinib—ABCB1—endocrine gland—germ cell cancer	3.78e-05	0.000441	CbGeAlD
Imatinib—CYP2D6—brain—germ cell cancer	3.76e-05	0.000438	CbGeAlD
Imatinib—Hypersensitivity—Methotrexate—germ cell cancer	3.74e-05	0.000313	CcSEcCtD
Imatinib—ABCB1—head—germ cell cancer	3.73e-05	0.000435	CbGeAlD
Imatinib—Asthenia—Methotrexate—germ cell cancer	3.64e-05	0.000305	CcSEcCtD
Imatinib—ABCB1—testis—germ cell cancer	3.6e-05	0.00042	CbGeAlD
Imatinib—Pruritus—Methotrexate—germ cell cancer	3.59e-05	0.000301	CcSEcCtD
Imatinib—Diarrhoea—Methotrexate—germ cell cancer	3.47e-05	0.000291	CcSEcCtD
Imatinib—Dizziness—Methotrexate—germ cell cancer	3.35e-05	0.000281	CcSEcCtD
Imatinib—ABCB1—cerebellum—germ cell cancer	3.33e-05	0.000388	CbGeAlD
Imatinib—Vomiting—Methotrexate—germ cell cancer	3.22e-05	0.00027	CcSEcCtD
Imatinib—Rash—Methotrexate—germ cell cancer	3.2e-05	0.000268	CcSEcCtD
Imatinib—Dermatitis—Methotrexate—germ cell cancer	3.19e-05	0.000268	CcSEcCtD
Imatinib—Headache—Methotrexate—germ cell cancer	3.18e-05	0.000266	CcSEcCtD
Imatinib—Nausea—Methotrexate—germ cell cancer	3.01e-05	0.000253	CcSEcCtD
Imatinib—ABCB1—brain—germ cell cancer	2.7e-05	0.000315	CbGeAlD
Imatinib—ABCB1—lymph node—germ cell cancer	2.61e-05	0.000305	CbGeAlD
Imatinib—ABL1—Integrated Breast Cancer Pathway—TP53—germ cell cancer	2.1e-05	0.000276	CbGpPWpGaD
Imatinib—KIT—Signaling by EGFR in Cancer—HRAS—germ cell cancer	2.09e-05	0.000274	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—FGFR3—germ cell cancer	2.08e-05	0.000274	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signaling of activated FGFR—HRAS—germ cell cancer	2.08e-05	0.000273	CbGpPWpGaD
Imatinib—KIT—Signaling by PDGF—HRAS—germ cell cancer	2.08e-05	0.000273	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—OXT—germ cell cancer	2.06e-05	0.00027	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by ERBB4—HRAS—germ cell cancer	2.05e-05	0.000269	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.05e-05	0.000269	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.02e-05	0.000265	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by FGFR in disease—HRAS—germ cell cancer	2.01e-05	0.000264	CbGpPWpGaD
Imatinib—PDGFRA—DAP12 interactions—HRAS—germ cell cancer	2.01e-05	0.000264	CbGpPWpGaD
Imatinib—PDGFRA—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	2.01e-05	0.000264	CbGpPWpGaD
Imatinib—ALB—Folate Metabolism—TP53—germ cell cancer	2e-05	0.000263	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—FGFR3—germ cell cancer	2e-05	0.000263	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by EGFR—HRAS—germ cell cancer	2e-05	0.000262	CbGpPWpGaD
Imatinib—KIT—Immune System—FGF4—germ cell cancer	1.99e-05	0.000261	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.98e-05	0.00026	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by EGFR in Cancer—HRAS—germ cell cancer	1.98e-05	0.00026	CbGpPWpGaD
Imatinib—PDGFRB—MAPK Signaling Pathway—TP53—germ cell cancer	1.98e-05	0.00026	CbGpPWpGaD
Imatinib—NTRK1—Signaling by NGF—HRAS—germ cell cancer	1.98e-05	0.00026	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.97e-05	0.000259	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—FGFR3—germ cell cancer	1.97e-05	0.000259	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by PDGF—HRAS—germ cell cancer	1.97e-05	0.000259	CbGpPWpGaD
Imatinib—KIT—B Cell Activation—HRAS—germ cell cancer	1.97e-05	0.000258	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signal transduction—HRAS—germ cell cancer	1.96e-05	0.000257	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by FGFR—HRAS—germ cell cancer	1.95e-05	0.000256	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by ERBB2—HRAS—germ cell cancer	1.94e-05	0.000254	CbGpPWpGaD
Imatinib—PDGFRB—DAP12 signaling—HRAS—germ cell cancer	1.93e-05	0.000253	CbGpPWpGaD
Imatinib—LCK—PDGFR-beta signaling pathway—HRAS—germ cell cancer	1.92e-05	0.000252	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—KITLG—germ cell cancer	1.92e-05	0.000252	CbGpPWpGaD
Imatinib—PDGFRA—Focal Adhesion—HRAS—germ cell cancer	1.9e-05	0.00025	CbGpPWpGaD
Imatinib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	1.9e-05	0.00025	CbGpPWpGaD
Imatinib—ABL1—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	1.9e-05	0.000249	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—FGFR3—germ cell cancer	1.89e-05	0.000249	CbGpPWpGaD
Imatinib—KIT—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	1.88e-05	0.000247	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—FGF4—germ cell cancer	1.88e-05	0.000247	CbGpPWpGaD
Imatinib—PDGFRA—B Cell Activation—HRAS—germ cell cancer	1.86e-05	0.000245	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—KITLG—germ cell cancer	1.84e-05	0.000242	CbGpPWpGaD
Imatinib—KIT—Disease—FGF4—germ cell cancer	1.84e-05	0.000241	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by FGFR in disease—HRAS—germ cell cancer	1.81e-05	0.000238	CbGpPWpGaD
Imatinib—PDGFRB—DAP12 interactions—HRAS—germ cell cancer	1.81e-05	0.000238	CbGpPWpGaD
Imatinib—PDGFRB—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	1.81e-05	0.000238	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—KIT—germ cell cancer	1.81e-05	0.000238	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by EGFR—HRAS—germ cell cancer	1.8e-05	0.000236	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	1.79e-05	0.000235	CbGpPWpGaD
Imatinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	1.78e-05	0.000234	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by EGFR in Cancer—HRAS—germ cell cancer	1.78e-05	0.000234	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—FGFR3—germ cell cancer	1.78e-05	0.000233	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by PDGF—HRAS—germ cell cancer	1.77e-05	0.000233	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—SLC2A3—germ cell cancer	1.77e-05	0.000233	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.77e-05	0.000233	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—SLC2A3—germ cell cancer	1.76e-05	0.000231	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—SLC2A3—germ cell cancer	1.76e-05	0.00023	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—FGF4—germ cell cancer	1.75e-05	0.00023	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—SLC22A3—germ cell cancer	1.75e-05	0.000229	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.75e-05	0.000229	CbGpPWpGaD
Imatinib—LCK—Signaling by SCF-KIT—HRAS—germ cell cancer	1.75e-05	0.000229	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.74e-05	0.000228	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—KIT—germ cell cancer	1.74e-05	0.000228	CbGpPWpGaD
Imatinib—PDGFRA—Disease—FGF4—germ cell cancer	1.74e-05	0.000228	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—SLC22A3—germ cell cancer	1.73e-05	0.000227	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—FGFR3—germ cell cancer	1.73e-05	0.000227	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—SLC22A3—germ cell cancer	1.73e-05	0.000227	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.73e-05	0.000227	CbGpPWpGaD
Imatinib—PDGFRB—Focal Adhesion—HRAS—germ cell cancer	1.71e-05	0.000225	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—FGFR3—germ cell cancer	1.71e-05	0.000224	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—SLC2A3—germ cell cancer	1.7e-05	0.000224	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—FGF4—germ cell cancer	1.7e-05	0.000222	CbGpPWpGaD
Imatinib—PDGFRB—B Cell Activation—HRAS—germ cell cancer	1.68e-05	0.00022	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—SLC22A3—germ cell cancer	1.68e-05	0.00022	CbGpPWpGaD
Imatinib—LCK—Downstream signaling of activated FGFR—HRAS—germ cell cancer	1.67e-05	0.000219	CbGpPWpGaD
Imatinib—ABL1—Immune System—FGF4—germ cell cancer	1.65e-05	0.000217	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB4—HRAS—germ cell cancer	1.65e-05	0.000216	CbGpPWpGaD
Imatinib—KIT—Disease—H2AFZ—germ cell cancer	1.64e-05	0.000215	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—SLC2A3—germ cell cancer	1.64e-05	0.000215	CbGpPWpGaD
Imatinib—KIT—Immune System—KITLG—germ cell cancer	1.63e-05	0.000214	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—KIT—germ cell cancer	1.63e-05	0.000214	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.62e-05	0.000212	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—SLC22A3—germ cell cancer	1.61e-05	0.000212	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.61e-05	0.000212	CbGpPWpGaD
Imatinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	1.61e-05	0.000211	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—KIT—germ cell cancer	1.59e-05	0.000209	CbGpPWpGaD
Imatinib—LCK—Downstream signal transduction—HRAS—germ cell cancer	1.57e-05	0.000206	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—KIT—germ cell cancer	1.57e-05	0.000206	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—H2AFZ—germ cell cancer	1.57e-05	0.000206	CbGpPWpGaD
Imatinib—PDGFRB—Disease—FGF4—germ cell cancer	1.57e-05	0.000205	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR—HRAS—germ cell cancer	1.56e-05	0.000205	CbGpPWpGaD
Imatinib—LCK—Signaling by ERBB2—HRAS—germ cell cancer	1.56e-05	0.000204	CbGpPWpGaD
Imatinib—PDGFRA—Disease—H2AFZ—germ cell cancer	1.55e-05	0.000204	CbGpPWpGaD
Imatinib—LCK—DAP12 signaling—HRAS—germ cell cancer	1.55e-05	0.000203	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—KITLG—germ cell cancer	1.55e-05	0.000203	CbGpPWpGaD
Imatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	1.53e-05	0.0002	CbGpPWpGaD
Imatinib—KIT—Disease—KITLG—germ cell cancer	1.51e-05	0.000198	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—OXT—germ cell cancer	1.51e-05	0.000198	CbGpPWpGaD
Imatinib—LCK—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	1.46e-05	0.000191	CbGpPWpGaD
Imatinib—LCK—Signaling by FGFR in disease—HRAS—germ cell cancer	1.46e-05	0.000191	CbGpPWpGaD
Imatinib—LCK—DAP12 interactions—HRAS—germ cell cancer	1.46e-05	0.000191	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—HRAS—germ cell cancer	1.45e-05	0.00019	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR—HRAS—germ cell cancer	1.44e-05	0.000189	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—KITLG—germ cell cancer	1.44e-05	0.000189	CbGpPWpGaD
Imatinib—LCK—Signaling by EGFR in Cancer—HRAS—germ cell cancer	1.43e-05	0.000188	CbGpPWpGaD
Imatinib—PDGFRA—Disease—KITLG—germ cell cancer	1.43e-05	0.000187	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—FGFR3—germ cell cancer	1.43e-05	0.000187	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—OXT—germ cell cancer	1.43e-05	0.000187	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CRABP1—germ cell cancer	1.42e-05	0.000187	CbGpPWpGaD
Imatinib—LCK—Signaling by PDGF—HRAS—germ cell cancer	1.42e-05	0.000187	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CRABP1—germ cell cancer	1.41e-05	0.000185	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CRABP1—germ cell cancer	1.41e-05	0.000185	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—AVP—germ cell cancer	1.41e-05	0.000185	CbGpPWpGaD
Imatinib—PDGFRB—Disease—H2AFZ—germ cell cancer	1.4e-05	0.000183	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—KITLG—germ cell cancer	1.39e-05	0.000183	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.38e-05	0.000181	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—HRAS—germ cell cancer	1.37e-05	0.00018	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—FGFR3—germ cell cancer	1.37e-05	0.00018	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CRABP1—germ cell cancer	1.37e-05	0.00018	CbGpPWpGaD
Imatinib—LCK—Immune System—FGF4—germ cell cancer	1.36e-05	0.000179	CbGpPWpGaD
Imatinib—ABL1—Immune System—KITLG—germ cell cancer	1.36e-05	0.000178	CbGpPWpGaD
Imatinib—LCK—B Cell Activation—HRAS—germ cell cancer	1.35e-05	0.000177	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CRABP1—germ cell cancer	1.31e-05	0.000172	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—KIT—germ cell cancer	1.31e-05	0.000172	CbGpPWpGaD
Imatinib—LCK—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	1.29e-05	0.000169	CbGpPWpGaD
Imatinib—PDGFRB—Disease—KITLG—germ cell cancer	1.29e-05	0.000169	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—FGF4—germ cell cancer	1.29e-05	0.000169	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—OXT—germ cell cancer	1.28e-05	0.000169	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—SLC2A3—germ cell cancer	1.27e-05	0.000167	CbGpPWpGaD
Imatinib—SLC22A2—Transmission across Chemical Synapses—HRAS—germ cell cancer	1.27e-05	0.000166	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—KIT—germ cell cancer	1.26e-05	0.000165	CbGpPWpGaD
Imatinib—LCK—Disease—FGF4—germ cell cancer	1.26e-05	0.000165	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—SLC22A3—germ cell cancer	1.25e-05	0.000164	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—HRAS—germ cell cancer	1.24e-05	0.000162	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—FGF4—germ cell cancer	1.22e-05	0.00016	CbGpPWpGaD
Imatinib—KIT—Immune System—FGFR3—germ cell cancer	1.21e-05	0.000159	CbGpPWpGaD
Imatinib—SLC22A1—Transmission across Chemical Synapses—HRAS—germ cell cancer	1.18e-05	0.000155	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—FGFR3—germ cell cancer	1.15e-05	0.000151	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—H2AFZ—germ cell cancer	1.15e-05	0.000151	CbGpPWpGaD
Imatinib—LCK—Disease—H2AFZ—germ cell cancer	1.12e-05	0.000147	CbGpPWpGaD
Imatinib—KIT—Disease—FGFR3—germ cell cancer	1.12e-05	0.000147	CbGpPWpGaD
Imatinib—LCK—Immune System—KITLG—germ cell cancer	1.12e-05	0.000147	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—FGF4—germ cell cancer	1.1e-05	0.000144	CbGpPWpGaD
Imatinib—ALB—Metabolism—SLC2A3—germ cell cancer	1.09e-05	0.000144	CbGpPWpGaD
Imatinib—ABL1—Axon guidance—HRAS—germ cell cancer	1.09e-05	0.000143	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—H2AFZ—germ cell cancer	1.09e-05	0.000143	CbGpPWpGaD
Imatinib—ALB—Metabolism—SLC22A3—germ cell cancer	1.08e-05	0.000142	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—AVP—germ cell cancer	1.08e-05	0.000141	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—FGFR3—germ cell cancer	1.07e-05	0.000141	CbGpPWpGaD
Imatinib—PDGFRA—Disease—FGFR3—germ cell cancer	1.06e-05	0.000139	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—KITLG—germ cell cancer	1.06e-05	0.000139	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—KIT—germ cell cancer	1.05e-05	0.000138	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—FGFR3—germ cell cancer	1.04e-05	0.000136	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—AVP—germ cell cancer	1.03e-05	0.000135	CbGpPWpGaD
Imatinib—LCK—Disease—KITLG—germ cell cancer	1.03e-05	0.000135	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—OXT—germ cell cancer	1.03e-05	0.000135	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CRABP1—germ cell cancer	1.02e-05	0.000134	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—HRAS—germ cell cancer	1.01e-05	0.000132	CbGpPWpGaD
Imatinib—ABL1—Immune System—FGFR3—germ cell cancer	1.01e-05	0.000132	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—KITLG—germ cell cancer	1e-05	0.000131	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—HRAS—germ cell cancer	9.92e-06	0.00013	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—KIT—germ cell cancer	9.83e-06	0.000129	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—SLC2A3—germ cell cancer	9.83e-06	0.000129	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—H2AFZ—germ cell cancer	9.79e-06	0.000128	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—AVP—germ cell cancer	9.77e-06	0.000128	CbGpPWpGaD
Imatinib—PDGFRA—Disease—KIT—germ cell cancer	9.74e-06	0.000128	CbGpPWpGaD
Imatinib—SLC22A2—Neuronal System—HRAS—germ cell cancer	9.7e-06	0.000127	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—SLC22A3—germ cell cancer	9.68e-06	0.000127	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—SLC2A3—germ cell cancer	9.59e-06	0.000126	CbGpPWpGaD
Imatinib—PDGFRB—Disease—FGFR3—germ cell cancer	9.56e-06	0.000125	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—KIT—germ cell cancer	9.5e-06	0.000125	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—SLC22A3—germ cell cancer	9.45e-06	0.000124	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	9.45e-06	0.000124	CbGpPWpGaD
Imatinib—ABL1—Immune System—KIT—germ cell cancer	9.26e-06	0.000122	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	9.14e-06	0.00012	CbGpPWpGaD
Imatinib—SLC22A1—Neuronal System—HRAS—germ cell cancer	9.04e-06	0.000119	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—SLC2A3—germ cell cancer	9.04e-06	0.000119	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—KITLG—germ cell cancer	9e-06	0.000118	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—SLC2A3—germ cell cancer	8.96e-06	0.000118	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—SLC22A3—germ cell cancer	8.9e-06	0.000117	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—SLC22A3—germ cell cancer	8.83e-06	0.000116	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—AVP—germ cell cancer	8.8e-06	0.000116	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—FGF4—germ cell cancer	8.8e-06	0.000115	CbGpPWpGaD
Imatinib—ALB—Metabolism—CRABP1—germ cell cancer	8.79e-06	0.000115	CbGpPWpGaD
Imatinib—PDGFRB—Disease—KIT—germ cell cancer	8.77e-06	0.000115	CbGpPWpGaD
Imatinib—LCK—Immune System—FGFR3—germ cell cancer	8.31e-06	0.000109	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—HRAS—germ cell cancer	8.27e-06	0.000109	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—TP53—germ cell cancer	7.98e-06	0.000105	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—HRAS—germ cell cancer	7.94e-06	0.000104	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CRABP1—germ cell cancer	7.89e-06	0.000104	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—H2AFZ—germ cell cancer	7.85e-06	0.000103	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—FGFR3—germ cell cancer	7.85e-06	0.000103	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—HRAS—germ cell cancer	7.83e-06	0.000103	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—HRAS—germ cell cancer	7.78e-06	0.000102	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CRABP1—germ cell cancer	7.7e-06	0.000101	CbGpPWpGaD
Imatinib—LCK—Disease—FGFR3—germ cell cancer	7.67e-06	0.000101	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SLC2A3—germ cell cancer	7.66e-06	0.000101	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—HRAS—germ cell cancer	7.63e-06	0.0001	CbGpPWpGaD
Imatinib—LCK—Immune System—KIT—germ cell cancer	7.63e-06	0.0001	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SLC22A3—germ cell cancer	7.54e-06	9.9e-05	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—HRAS—germ cell cancer	7.52e-06	9.86e-05	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	7.5e-06	9.85e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—FGFR3—germ cell cancer	7.43e-06	9.75e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CRABP1—germ cell cancer	7.26e-06	9.53e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—KITLG—germ cell cancer	7.23e-06	9.48e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CRABP1—germ cell cancer	7.2e-06	9.44e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—AVP—germ cell cancer	7.06e-06	9.27e-05	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—HRAS—germ cell cancer	7.05e-06	9.25e-05	CbGpPWpGaD
Imatinib—LCK—Disease—KIT—germ cell cancer	7.04e-06	9.24e-05	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—HRAS—germ cell cancer	6.87e-06	9.02e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—KIT—germ cell cancer	6.82e-06	8.95e-05	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—HRAS—germ cell cancer	6.77e-06	8.89e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—FGFR3—germ cell cancer	6.69e-06	8.78e-05	CbGpPWpGaD
Imatinib—LCK—Hemostasis—TP53—germ cell cancer	6.57e-06	8.63e-05	CbGpPWpGaD
Imatinib—LCK—Hemostasis—HRAS—germ cell cancer	6.29e-06	8.25e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CRABP1—germ cell cancer	6.15e-06	8.07e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—KIT—germ cell cancer	6.14e-06	8.06e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SLC2A3—germ cell cancer	5.91e-06	7.76e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SLC22A3—germ cell cancer	5.82e-06	7.64e-05	CbGpPWpGaD
Imatinib—KIT—Disease—MYC—germ cell cancer	5.66e-06	7.43e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—HRAS—germ cell cancer	5.66e-06	7.43e-05	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—HRAS—germ cell cancer	5.43e-06	7.13e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—MYC—germ cell cancer	5.41e-06	7.1e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—FGFR3—germ cell cancer	5.37e-06	7.05e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—MYC—germ cell cancer	5.36e-06	7.03e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—KIT—germ cell cancer	4.93e-06	6.47e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—MYC—germ cell cancer	4.83e-06	6.34e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—HRAS—germ cell cancer	4.82e-06	6.32e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CRABP1—germ cell cancer	4.75e-06	6.23e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—HRAS—germ cell cancer	4.56e-06	5.98e-05	CbGpPWpGaD
Imatinib—KIT—Disease—HRAS—germ cell cancer	4.45e-06	5.84e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TP53—germ cell cancer	4.44e-06	5.83e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HRAS—germ cell cancer	4.25e-06	5.58e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—HRAS—germ cell cancer	4.21e-06	5.52e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—HRAS—germ cell cancer	4.11e-06	5.39e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—HRAS—germ cell cancer	4e-06	5.25e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—MYC—germ cell cancer	3.96e-06	5.2e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TP53—germ cell cancer	3.93e-06	5.16e-05	CbGpPWpGaD
Imatinib—LCK—Disease—MYC—germ cell cancer	3.87e-06	5.09e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—HRAS—germ cell cancer	3.79e-06	4.98e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—HRAS—germ cell cancer	3.76e-06	4.93e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—MYC—germ cell cancer	3.75e-06	4.93e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MYC—germ cell cancer	3.38e-06	4.44e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—HRAS—germ cell cancer	3.3e-06	4.33e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TP53—germ cell cancer	3.26e-06	4.27e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HRAS—germ cell cancer	3.11e-06	4.09e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TP53—germ cell cancer	3.08e-06	4.04e-05	CbGpPWpGaD
Imatinib—LCK—Disease—HRAS—germ cell cancer	3.04e-06	3.99e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HRAS—germ cell cancer	2.95e-06	3.87e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TP53—germ cell cancer	2.78e-06	3.64e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MYC—germ cell cancer	2.71e-06	3.56e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HRAS—germ cell cancer	2.66e-06	3.49e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TP53—germ cell cancer	2.23e-06	2.92e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HRAS—germ cell cancer	2.13e-06	2.8e-05	CbGpPWpGaD
